Rubric Capital Management LP

Institutional investor · Portfolio as of Q1 2020

Q1 2020 biggest moves
  • DDDD

    DuPont de Nemours

    Sold out

    was 5.1% of portfolio

  • MOMO

    Altria

    Sold out

    was 5.0% of portfolio

  • DELLDELL

    Dell Technologies

    Sold out

    was 4.9% of portfolio

  • CNCCNC

    Centene

    New

    5.8% of portfolio

65 changes in all

Top Holdings52 positions

Checking export access…
Activity:
CNC

Centene Corporation

614,242$36.5M5.8%$59.41+6.97%
1 qtr
New
90
CVS

CVS Health Corporation

546,500$32.4M5.1%$47.770.00%
1 qtr
New
90
MIC
MICDelisted
Unit

MACQUARIE INFRASTR HOLD LLC

1.2M$31.1M4.9%——
2 qtrssince 2019-Q4
Increased
75
MX

Magnachip Semiconductor Corporation

2.5M$27.8M4.4%$11.58-4.56%
2 qtrssince 2019-Q4
Increased
57
PCG

PG&E Corporation

3.1M$27.6M4.4%$8.800.00%
1 qtr
New
81
CHNG
CHNGDelisted

CHANGE HEALTHCARE INC

2.6M$25.9M4.1%——
2 qtrssince 2019-Q4
Increased
86
CHRS

Coherus Oncology, Inc.

1.6M$25.7M4.1%$18.01-9.91%
2 qtrssince 2019-Q4
Decreased
0
TLND
TLNDDelisted
ADR

TALEND SA - ADR

1M$23M3.6%——
1 qtr
New
80
ALXN
ALXNDelisted

ALEXION PHARMACEUTICALS INC

255,000$22.9M3.6%——
1 qtr
New
80
QNST

QuinStreet, Inc.

2.8M$22.7M3.6%$14.01-42.53%
2 qtrssince 2019-Q4
Increased
64
VICI
VICI
REIT

VICI Properties Inc.

1.3M$21.9M3.5%$11.68+23.17%
1 qtr
New
80
IDCC

InterDigital, Inc.

476,956$21.3M3.4%$39.700.00%
1 qtr
New
80
WSC

WillScot Holdings Corporation

2.1M$21M3.3%———
—
TBPH
TBPHDelisted

THERAVANCE BIOPHARMA INC

873,577$20.2M3.2%——
2 qtrssince 2019-Q4
Increased
85
COLL

Collegium Pharmaceutical, Inc.

1.2M$19.8M3.1%$16.330.00%
1 qtr
New
80
STML
STMLDelisted

STEMLINE THERAPEUTICS INC

3.3M$16.2M2.6%——
2 qtrssince 2019-Q4
Decreased
0
RDUS
RDUSDelisted

RADIUS HEALTH INC

1.2M$16M2.5%——
2 qtrssince 2019-Q4
Decreased
0
MGP
MGPDelisted
REIT

MGM GROWTH PPTYS LLC

630,307$14.9M2.4%——
1 qtr
New
74
BGCP
BGCPDelisted

BGC PARTNERS INC

5.8M$14.6M2.3%——
2 qtrssince 2019-Q4
Decreased
0
BDSI
BDSIDelisted

BIODELIVERY SCIENCES INTL

3.8M$14.3M2.3%——
2 qtrssince 2019-Q4
Increased
67
$633.2M
AUM
52
Positions
Q1 2020
Filing
HI rating · 2.5/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q1'20
New32%Increased7%Decreased22%Exited40%
Composition
Equity vs derivatives
Equity97%Puts3%Calls1%
Holding period
Avg 1.3 years
<1Q44%1-4Q0%1-2Y0%2Y+56%

Rubric Capital Management LP manages $633.2M across 52 positions as of Q1 2020. Top holdings: CNC (5.8%), CVS (5.1%), MIC (4.9%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 2.5/5.0.

Top holdings by portfolio weight

Total AUM$612M
CNC5.76%
CVS5.12%
MIC4.91%
MX4.38%
PCG4.36%
CHNG4.10%
CHRS4.06%
TLND3.63%
ALXN3.62%
QNST3.58%
Other3.46%

Portfolio allocation by GICS sector

Sectors10
Unknown36.09%
Healthcare27.84%
Technology15.18%
Communication Services4.85%
Utilities4.60%
Industrials4.47%
Real Estate3.65%
Basic Materials1.73%
Energy1.19%
Consumer Defensive0.40%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Unknown, Healthcare, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(2.5 / 5.0)
Holdings P&L34
Conviction64
Concentration69
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GEOGEOThe Geo Group Inc
Q2 2025 → Q3 2026+4.5M shares+$138.3M
5Q
BGCBGCBGC Group, Inc.
Q3 2025 → Q3 2026+9.3M shares+$129.2M
5Q
VTRSVTRSViatris Inc.
Q3 2025 → Q3 2026+24M shares+$530.8M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used